Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV003493553 | SCV004242964 | uncertain significance | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003727640 | SCV004539142 | uncertain significance | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 318 of the KLF1 protein (p.Trp318Cys). This variant is present in population databases (rs769526751, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of KLF1-related conditions (PMID: 30222867, 34535703). ClinVar contains an entry for this variant (Variation ID: 253309). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KLF1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Australian Red Cross Blood Service | RCV000240027 | SCV000298179 | affects | BLOOD GROUP--LUTHERAN INHIBITOR | 2016-08-09 | no assertion criteria provided | research | Serologic Lu(a-b-) phenotype but massively parallel sequencing did not identify any variants in the BCAM gene that could explain this phenotype. Reduced BCAM and CD44 expression by flow cytometry. |